PARTI General Burzynski Research Institute,Inc. (the Company) was incorporated under the laws of the State of Delaware in 1984 in order to engage in the research, production, marketing, promotion and sale of certain medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives and organic acids which are known under the trade name Antineoplastons. The Company believes Antineoplastons are useful in the treatment of human cancer and is currently reviewing data of its Ph...
Q2 FY2026 — expected 2026-07-10
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-05-20 | 2025-02-28 | 0001558370-25-008021 | EDGAR | 33K words |
| 2024-05-29 | 2024-02-29 | 0001558370-24-008731 | EDGAR | — |
| 2023-05-25 | 2023-02-28 | 0001558370-23-010476 | EDGAR | — |
| 2022-05-26 | 2022-02-28 | 0001558370-22-009398 | EDGAR | — |
| 2021-05-24 | 2021-02-28 | 0001104659-21-071200 | EDGAR | — |
| 2020-05-28 | 2020-02-29 | 0001104659-20-067054 | EDGAR | — |
| 2019-05-29 | 2019-02-28 | 0001104659-19-032421 | EDGAR | — |
| 2018-05-22 | 2018-02-28 | 0001104659-18-035071 | EDGAR | — |
| 2017-05-11 | 2017-02-28 | 0001104659-17-031953 | EDGAR | — |
| 2016-06-13 | 2016-02-29 | 0001104659-16-126875 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-01-13 | 2025-11-30 | 0001104659-26-003337 | EDGAR | 11K words |
| 2025-10-14 | 2025-08-31 | 0001104659-25-099284 | EDGAR | — |
| 2025-07-15 | 2025-05-31 | 0001558370-25-009242 | EDGAR | — |
| 2025-01-13 | 2024-11-30 | 0001558370-25-000165 | EDGAR | — |
| 2024-10-10 | 2024-08-31 | 0001558370-24-013239 | EDGAR | — |
| 2024-07-15 | 2024-05-31 | 0001558370-24-009817 | EDGAR | — |
| 2024-01-16 | 2023-11-30 | 0001558370-24-000294 | EDGAR | — |
| 2023-10-12 | 2023-08-31 | 0001558370-23-016401 | EDGAR | — |
| 2023-07-13 | 2023-05-31 | 0001558370-23-011866 | EDGAR | — |
| 2023-01-13 | 2022-11-30 | 0001558370-23-000269 | EDGAR | — |
| 2022-10-13 | 2022-08-31 | 0001558370-22-014980 | EDGAR | — |
| 2022-07-14 | 2022-05-31 | 0001558370-22-010716 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2025-07-24 | 0001104659-25-070376 | EDGAR | 1K words |
| 2023-05-22 | 0001104659-23-063151 | EDGAR | — |
| 2023-04-06 | 0001104659-23-042811 | EDGAR | — |
| 2021-10-06 | 0001104659-21-123645 | EDGAR | — |
| 2013-07-08 | 0001104659-13-053518 | EDGAR | — |
| 2012-07-06 | 0001104659-12-047927 | EDGAR | — |
| 2012-03-01 | 0001104659-12-014985 | EDGAR | — |
| 2011-09-12 | 0001104659-11-051249 | EDGAR | — |
| 2009-05-22 | 0001104659-09-034645 | EDGAR | — |
| 2006-01-24 | 0000950129-06-000545 | EDGAR | — |
87 total filings indexed. 55 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000724445 |
| Ticker | BZYR |
| Exchange | OTC |
| SIC | 2835: In Vitro & In Vivo Diagnostic Substances |
| Incorporated | DE |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report